-
Real Time Chart
-
Stock Profile
-
Stock Fundamentals
Financials As Reported
-
accession Number
0000950170-23-003068
-
amendment Flag
false
-
auditor Firm Id
1,294
-
auditor Location
Copenhagen, Denmark
-
auditor Name
Deloitte Statsautoriseret Revisionspartnerselskab
-
cik
1,612,042
-
current Fiscal Year End Date
--12-31
-
date Filed
2023-02-16
-
document Annual Report
true
-
document Fiscal Period Focus
FY
-
document Fiscal Year Focus
2,022
-
document Period End Date
2022-12-31
-
document Transition Report
false
-
document Type
20-F
-
entity Address Address Line 1
Tuborg Boulevard 12
-
entity Address City Or Town
Hellerup
-
entity Address Postal Zip Code
DK-2900
-
entity Central Index Key
1,612,042
-
entity Current Reporting Status
Yes
-
entity Emerging Growth Company
false
-
entity File Number
001-36815
-
entity Filer Category
Large Accelerated Filer
-
entity Incorporation State Country Code
G7
-
entity Interactive Data Current
Yes
-
entity Name
Ascendis Pharma A/S
-
entity Registrant Name
Ascendis Pharma A/S
-
entity Shell Company
false
-
entity Voluntary Filers
No
-
entity Well Known Seasoned Issuer
Yes
-
icfr Auditor Attestation Flag
true
-
irs Number
0
-
period End
1,672,444,800,000
-
period Start
1,640,995,200,000
-
report Link
https://www.sec.gov/Archives/edgar/data/1612042/000095017023003068/asnd-20221231_htm.xml
-
trading Symbol
ASND
-
update
1970-01-01
-
id
REPORTED_FINANCIALS
-
key
ASND
-
subkey
20-F
-
date
2023-02-16
-
updated
2023-02-17
-
Symbol Info
-
Symbol Over View
-
Technical Analysis
ASND stock fundamentals - financials as reported